치과임상에서 편두통 치료에 대한 제안
A proposal for management of migraine in dental clinic
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
흔한 중증 원발 두통 질환 중 하나인 편두통의 치료법에는 두통 일기 작성, 생활습관 개선, 운동 및 이완요법, 인지행동요법, 신경자극 등을 비롯한 비약물치료와 약물치료 등 다양한 전략이 있다. 본 종설은 이 중 약물 치료를 두통의 강도와 빈도에 기반하여 급성기치료와 예방치료로 나누어 고찰하고, 약물 치료의 효과를 극대화 시키기 위한 방법 및 편두통 치료의 최신 지견을 소개하고자 한다.
Abstract
Management of migraine, one of common primary headache disorders, involves the diverse strategies non-pharmacological treatment, such as headache diary, lifestyle modification, regular exercise and relaxation, cognitive behavioral therapy and neurostimulation, and pharmacological treatment. Among the treatments, this review described a pharmacologic treatment of migraine, classified into acute and preventive treatment based on the severity and the frequency of headache. It introduced the way to optimize pharmacological treatment and updated the latest treatment for migraine.
참고문헌 (15)
- Lee TG CK, "Prevalence of migraine in Korean adults: a nationwide survey", Korean J Headache, 1, pp.57~66 (2000)
- Headache Classification Committee of the International Headache Society (IHS), "The International Classification of Headache Disorders, 3rd edition", Cephalalgia, 38, pp.1~211 (2018)
- 이혜진, "치과임상에서의 두통의 진단", 구강회복응용과학지, 32(2), pp.102~108 (2016), 대한턱관절교합학회[DOI]
- 김병건, "Comprehensive Application of the International Classification of Headache Disorders Third Edition, Beta Version", Journal of Korean Medical Science, 31(1), pp.106~113 (2016), 대한의학회
- Brennum J, "Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache", Eur J Neurol 1996;, 3, pp.23~28 (1996)
- Silberstein SD, "Practice parameter: evidence-based guidelines for migraine headache (an evidencebased review): report of the Quality Standards Subcommittee of the American Academy of Neurology", Neurology, 55, pp.754~762 (2000)
- Marmura MJ, "The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies", Headache, 55, pp.3~20 (2015)
- Laurell K, "Premonitory symptoms in migraine: A cross-sectional study in 2714 persons", Cephalalgia, 36, pp.951~959 (2016)
- Lipton RB, "Migraine prevalence, disease burden, and the need for preventive therapy", Neurology, 68, pp.343~349 (2007)
- Ashkenazi A, "OnabotulinumtoxinA for the treatment of headache", Headache, 53(Suppl 2), pp.54~61 (2013)
- Steiner TJ, "European Headache Federation and Lifting The Burden: the Global Campaign against Headache. Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence", J Headache Pain, 20, pp.24~ (2019)
- Stewart WF, "Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability", Neurology, 56, pp.S20~S28 (2001)
- Silberstein SD, "Evidencebased guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society", Neurology, 78, pp.1337~1345 (2012)
- Allergan I, "BOTOX® Chronic Migraine Reconstitution and Injection Workshop Guide", ~ (2010)
- "Cefaly"[URL]
